Verona Pharma PLC Holding(s) in Company (1048G)
August 03 2016 - 3:44AM
UK Regulatory
TIDMVRP
RNS Number : 1048G
Verona Pharma PLC
03 August 2016
i
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
(i)
1. Identity of the issuer or
the underlying issuer of existing
shares to which voting rights Verona Pharma plc
are attached: ii
------------------------------------------------------------- --------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------- ------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------- ------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------- ------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------- ------------------------------------
Other (please specify):
--------------------------------------------------------------- ------------------------------------
3. Full name of person(s)
subject to the notification Vivo Ventures VI, LLC
obligation: iii
----------------------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) Vivo Ventures fund VI, LP
(if different from 3.):iv Vivo Ventures VI Affiliates
Fund, LP
----------------------------------------------------------- ----------------------------------------
5. Date of the transaction
and date on which the threshold July 29, 2016
is crossed or
reached: v
----------------------------------------------------------- ----------------------------------------
6. Date on which issuer notified: July 29, 2016
----------------------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are
crossed or reached: vi, vii 1.62% to 2.46% Change at Combined
Interest Level
----------------------------------------------------------- ----------------------------------------
8. Notified details:
---------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares viii, ix
---------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of shares to the triggering triggering transaction
transaction
if possible
using the
ISIN CODE
---------------- ---------------------------- ---------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights x
Shares Voting
Rights
---------------- ------------- ------------- ------------- ------------------------ ----------------------
Direct Direct Indirect Direct Indirect
xi xii
---------------- ------------- ------------- ------------- --------- ------------- --------- -----------
GB00B06GSH43 16,400,000 16,400,000 63,098,468 63,098,468 2.46%
---------------- ------------- ------------- ------------- --------- ------------- --------- -----------
B: Qualifying Financial Instruments
---------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Conversion Number of voting % of voting
instrument date xiii Period xiv rights that rights
may be
acquired if
the instrument
is
exercised/ converted.
------------------ ----------- --------------------- ----------------------- ------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
xv, xvi
---------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date xvii Conversion rights instrument rights xix,
period refers to xx
xviii
------------------ --------- ----------- ------------ ------------------- --------------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- ---------- --------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
63,098,468 2.46%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held, if
applicable: xxi
Vivo Ventures VI, LLC is the general partner of both Vivo
Ventures Fund VI, LP (VV Fund VI) and Vivo Ventures VI Affiliates
Fund, LP. (Affiliates Fund VI). Accordingly, Vivo Ventures VI, LLC
may be deemed to have indirect beneficial ownership of shares of
the Issuer directly owned by VV Fund VI and Affiliates Fund VI. As
of the date of this filing, VV Fund VI and Affiliates
Fund VI beneficially own 62,639,570 and 458,898 shares of Common
respectively.
Proxy Voting:
----------------------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
-------------------------------------- ------------------------------------------------------
11. Number of voting rights proxy
holder will cease to hold:
-------------------------------------- ------------------------------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
-------------------------------------- ------------------------------------------------------
13. Additional information:
--------------------------------- --------------------------------
Vivo Capital, LLC Attn: Cinthia
14. Contact name: Sheu
--------------------------------- --------------------------------
15. Contact telephone number: +1-650-688-0818
--------------------------------- --------------------------------
Note: Annex should only be submitted to the FCA not the
issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to
the notification obligation
---------------------------------------------------------------------------------------
Full name
(including legal form of legal Vivo Ventures VI, LLC
entities)
-------------------------------- -----------------------------------------------------
Contact address
(registered office for legal 575 High Street, suite 201,
entities) Palo Alto, CA 94301
-------------------------------- -----------------------------------------------------
Phone number & email
650-688-0818; acha@vivocapital.net
-------------------------------- -----------------------------------------------------
Other useful information
(at least legal representative Albert Cha, Managing Member
for legal persons)
-------------------------------- -----------------------------------------------------
B: Identity of the notifier, if applicable
------------------------------------------------------------------------
Full name
Albert Cha
--------------------------------- -------------------------------------
Contact address
575 High Street, suite 201,
Palo Alto, CA 94301
--------------------------------- -------------------------------------
Phone number & email
650-688-0818; acha@vivocapital.net
--------------------------------- -------------------------------------
Other useful information
(e.g. functional relationship Albert Cha, Managing Member
with the person or legal entity
subject to the notification
obligation)
--------------------------------- -------------------------------------
C: Additional information
For notes on how to complete form TR-1 please see the FCA
website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGUUWRUPQUMW
(END) Dow Jones Newswires
August 03, 2016 03:44 ET (07:44 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jul 2023 to Jul 2024
